Your session is about to expire
← Back to Search
Other
Omega-3 Topical Products for Eczema
N/A
Recruiting
Led By Samuel P Fortin, Ph.D
Research Sponsored by SCF Pharma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Participant aged of at least 18 years old
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial will study the effects of Omega-3 serum & cream on 8 people with eczema, recording adverse effects & severity after 42 days.
Who is the study for?
This trial is for adults over 18 with eczema who haven't used corticosteroids in the last two weeks. Participants must be able to commit to the full study duration, understand and sign an informed consent form, and follow research staff instructions.
What is being tested?
The study tests a daily application of Omega-3 serum and cream on eczema-affected skin for forty-two days. It aims to assess changes in eczema severity and investigate the products' prebiotic effects on the skin.
What are the potential side effects?
While this study will monitor adverse effects, specific side effects are not listed. However, typical reactions may include skin irritation or allergic responses due to topical product use.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Impact of treatment on participant's self-assessment of eczema severity
Quantification by qPCR of the four main bacteria of the skin microbiota at the targeted eczema zone.
Secondary study objectives
Assessment of potential adverse effects of treatment
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Group B: Serum and Cream of formulation B (rich)Experimental Treatment1 Intervention
Daily application of glyceryl Eicosapentaenoate serum and glyceryl Eicosapentaenoate cream of formulation B on the targeted skin area. The skin area must be clean and dry. Subjects must proceed with at least one application of products each day for 42 consecutive days. Subjects may proceed with additional daily product applications if needed.
Group II: Group A: Serum and Cream of formulation A (light)Experimental Treatment1 Intervention
Daily application of glyceryl Eicosapentaenoate serum and glyceryl Eicosapentaenoate cream of formulation A on the targeted skin area. The skin area must be clean and dry. Subjects must proceed with at least one application of products each day for 42 consecutive days. Subjects may proceed with additional daily product applications if needed.
Find a Location
Who is running the clinical trial?
SCF PharmaLead Sponsor
6 Previous Clinical Trials
326 Total Patients Enrolled
Institut de recherche clinique du littoral (IRCL)UNKNOWN
2 Previous Clinical Trials
81 Total Patients Enrolled
Samuel P Fortin, Ph.DPrincipal InvestigatorSCF Pharma